Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 13/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.38 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.38 |
| ▸ | CDK9 | P50750 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31704700 | 0.90 | NAMPT (0.48) | NAMPTATMCYP11B2CYP2A6CYP11B1 | |
| SCHEMBL31706700 | 0.87 | NAMPT (0.43) | NAMPTCYP11B2 | |
| Lithium Ion SCHEMBL31704850 | 0.85 | NAMPT (0.42) | NAMPT | |
| Lithium Ion SCHEMBL31705374 | 0.85 | NAMPT (0.42) | NAMPT | |
| SCHEMBL31704818 | 0.84 | QDPR (0.51) | NAMPTATMCYP11B2CYP2A6CYP11B1 | |
| SCHEMBL31705649 | 0.82 | NAMPT (0.42) | NAMPTCCNT1CDK9 | |
| SCHEMBL31704732 | 0.80 | CCNT1 (0.44) | NAMPTCCNT1CDK9 | |
| SCHEMBL31705879 | 0.80 | CYP11B2 (0.56) | NAMPTATMCYP11B2 | |
| SCHEMBL31705195 | 0.79 | NAMPT (0.41) | NAMPTCCNT1CDK9 | |
| SCHEMBL31705209 | 0.79 | NAMPT (0.41) | NAMPTCCNT1CDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025215110-A1 | NEW AMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS SOS1 INHIBITORS | LES LABORATOIRES SERVIER (FR) | 2025-10-16 | — | — | WO | disclosed |